VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ScreenerBreakoutsScannerWatchlist
VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HomeSectorsHealthcare
Sector AnalysisETF: XLVUpdated Nov 20, 2026

Healthcare Sector Stocks: Performance, Valuations & Industry Comps

Driven by GLP-1 growth leaders like Eli Lilly, healthcare trades at a 19x Forward P/E. This dashboard tracks valuation trends, equal-weight performance, and sector component data across all 900+ pharmaceutical, biotech, and medical device stocks.

Sector Market Cap

$6.64T

Tracks 1024 stocks · top 50 by market cap

Median YTD Return

+11.7%

Screener universe · median stock return

Median P/E

33.5x

Screener stocks · excludes outliers

Median Dividend Yield

1.89%

Screener stocks · excludes zeros

Explore Screener
Review ValuationsFull Screener →
VCP Scanner Editorial Team
Research ByVCP Scanner Editorial Team
Jump ToPerformanceScreenerValuationIndustriesOutlookKey MetricsEarningsLearnFAQ
Loading Performance Chart...

Sector Screener

Rank the Healthcare with daily updated market and fundamental data

Scan the sector leaders, compare valuations and fundamentals, then open the full screener to refine your criteria.

Quick screens:Large Cap Healthcare→Profitable Healthcare→Dividend Healthcare→Growth Healthcare→
Filter by:
Compare Top 3 Open Screener
TickerCompanyPriceMkt CapP/EROEDiv Yield
LLY logoLLY
Eli Lilly and Company$1353.88$1.27T43.9101.2%0.4%
JNJ logoJNJ
Johnson & Johnson$270.86$652.01B41.235%1.9%
ABBV logoABBV
AbbVie Inc.$288.46$509.65B49.46214.7%2.3%
MRK logoMRK
Merck & Co., Inc.$135.09$333.65B136.736.9%2.4%
UNH logoUNH
UnitedHealth Group Incorporated$345.98$314.2B19.611.8%2.5%
NVS logoNVS
Novartis AG$151.91$288.74B28.831%2.6%
AZN logoAZN
AstraZeneca PLC$175.63$273.98B24.922.9%1.8%
TMO logoTMO
Thermo Fisher Scientific Inc.$678.23$252.04B35.513.1%0.2%
AMGN logoAMGN
Amgen Inc.$439.50$237.2B25.6106.1%2.2%
GILD logoGILD
Gilead Sciences, Inc.$168.69$209.45B-54.640.7%1.9%
ABT logoABT
Abbott Laboratories$104.14$181.39B38.513%2.3%
NVO logoNVO
Novo Nordisk A/S$38.51$171.01B10.360.7%4.4%
PFE logoPFE
Pfizer Inc.$27.56$157.08B39.38.9%6.2%
DHR logoDHR
Danaher Corporation$223.21$156.91B36.47.1%0.6%
ISRG logoISRG
Intuitive Surgical, Inc.$405.91$143.4B48.316.6%—
VRTX logoVRTX
Vertex Pharmaceuticals Incorporated$523.48$132.86B33.622.5%—
MDT logoMDT
Medtronic plc$101.49$130.3B24.99.8%2.8%
MCK logoMCK
McKesson Corporation$1086.45$126.79B27.0—0.3%
BMY logoBMY
Bristol-Myers Squibb Company$59.38$121.27B13.240.4%4.2%
SYK logoSYK
Stryker Corporation$315.34$120.89B33.515.1%1.1%
SNY logoSNY
Sanofi$46.60$111.91B24.410.4%4.6%
CVS logoCVS
CVS Health Corp.$82.13$104.79B9.62.3%3.3%
HCA logoHCA
HCA Healthcare, Inc.$473.69$102.55B15.2—0.6%
GSK logoGSK
GSK plc$48.22$96.61B17.339.4%3.3%
REGN logoREGN
Regeneron Pharmaceuticals, Inc.$931.98$96.01B20.414.9%0.4%
ELV logoELV
Elevance Health Inc.$405.56$87.95B17.213.3%1.7%
MRNA logoMRNA
Moderna, Inc.$198.69$78.84B-30.6-28.9%—
CI logoCI
Cigna Corporation$278.97$73.8B12.314.3%2.2%
TAK logoTAK
Takeda Pharmaceutical Company Limited$21.89$69.65B29.02.8%2.8%
COR logoCOR
Cencora, Inc.$344.56$67.04B19.0128.4%0.7%
LLY logoLLY
Eli Lilly and Company
$1353.88Price
Mkt Cap$1.27T
P/E43.9
ROE101.2%
Div Yield0.4%
JNJ logoJNJ
Johnson & Johnson
$270.86Price
Mkt Cap$652.01B
P/E41.2
ROE35%
Div Yield1.9%
ABBV logoABBV
AbbVie Inc.
$288.46Price
Mkt Cap$509.65B
P/E49.4
ROE6214.7%
Div Yield2.3%
MRK logoMRK
Merck & Co., Inc.
$135.09Price
Mkt Cap$333.65B
P/E136.7
ROE36.9%
Div Yield2.4%
UNH logoUNH
UnitedHealth Group Incorporated
$345.98Price
Mkt Cap$314.2B
P/E19.6
ROE11.8%
Div Yield2.5%
NVS logoNVS
Novartis AG
$151.91Price
Mkt Cap$288.74B
P/E28.8
ROE31%
Div Yield2.6%
AZN logoAZN
AstraZeneca PLC
$175.63Price
Mkt Cap$273.98B
P/E24.9
ROE22.9%
Div Yield1.8%
TMO logoTMO
Thermo Fisher Scientific Inc.
$678.23Price
Mkt Cap$252.04B
P/E35.5
ROE13.1%
Div Yield0.2%
AMGN logoAMGN
Amgen Inc.
$439.50Price
Mkt Cap$237.2B
P/E25.6
ROE106.1%
Div Yield2.2%
GILD logoGILD
Gilead Sciences, Inc.
$168.69Price
Mkt Cap$209.45B
P/E-54.6
ROE40.7%
Div Yield1.9%
ABT logoABT
Abbott Laboratories
$104.14Price
Mkt Cap$181.39B
P/E38.5
ROE13%
Div Yield2.3%
NVO logoNVO
Novo Nordisk A/S
$38.51Price
Mkt Cap$171.01B
P/E10.3
ROE60.7%
Div Yield4.4%
PFE logoPFE
Pfizer Inc.
$27.56Price
Mkt Cap$157.08B
P/E39.3
ROE8.9%
Div Yield6.2%
DHR logoDHR
Danaher Corporation
$223.21Price
Mkt Cap$156.91B
P/E36.4
ROE7.1%
Div Yield0.6%
ISRG logoISRG
Intuitive Surgical, Inc.
$405.91Price
Mkt Cap$143.4B
P/E48.3
ROE16.6%
Div Yield—
VRTX logoVRTX
Vertex Pharmaceuticals Incorporated
$523.48Price
Mkt Cap$132.86B
P/E33.6
ROE22.5%
Div Yield—
MDT logoMDT
Medtronic plc
$101.49Price
Mkt Cap$130.3B
P/E24.9
ROE9.8%
Div Yield2.8%
MCK logoMCK
McKesson Corporation
$1086.45Price
Mkt Cap$126.79B
P/E27.0
ROE—
Div Yield0.3%
BMY logoBMY
Bristol-Myers Squibb Company
$59.38Price
Mkt Cap$121.27B
P/E13.2
ROE40.4%
Div Yield4.2%
SYK logoSYK
Stryker Corporation
$315.34Price
Mkt Cap$120.89B
P/E33.5
ROE15.1%
Div Yield1.1%
SNY logoSNY
Sanofi
$46.60Price
Mkt Cap$111.91B
P/E24.4
ROE10.4%
Div Yield4.6%
CVS logoCVS
CVS Health Corp.
$82.13Price
Mkt Cap$104.79B
P/E9.6
ROE2.3%
Div Yield3.3%
HCA logoHCA
HCA Healthcare, Inc.
$473.69Price
Mkt Cap$102.55B
P/E15.2
ROE—
Div Yield0.6%
GSK logoGSK
GSK plc
$48.22Price
Mkt Cap$96.61B
P/E17.3
ROE39.4%
Div Yield3.3%
REGN logoREGN
Regeneron Pharmaceuticals, Inc.
$931.98Price
Mkt Cap$96.01B
P/E20.4
ROE14.9%
Div Yield0.4%
ELV logoELV
Elevance Health Inc.
$405.56Price
Mkt Cap$87.95B
P/E17.2
ROE13.3%
Div Yield1.7%
MRNA logoMRNA
Moderna, Inc.
$198.69Price
Mkt Cap$78.84B
P/E-30.6
ROE-28.9%
Div Yield—
CI logoCI
Cigna Corporation
$278.97Price
Mkt Cap$73.8B
P/E12.3
ROE14.3%
Div Yield2.2%
TAK logoTAK
Takeda Pharmaceutical Company Limited
$21.89Price
Mkt Cap$69.65B
P/E29.0
ROE2.8%
Div Yield2.8%
COR logoCOR
Cencora, Inc.
$344.56Price
Mkt Cap$67.04B
P/E19.0
ROE128.4%
Div Yield0.7%
See all 50 stocks →

Sector Outlook

Healthcare Sector Outlook - Q1 2026

Updated Q1 2026

Healthcare enters 2026 with a mixed setup. Large-cap pharma and managed care provide cash flow stability, while biotech depends on funding conditions, catalysts, and M&A appetite.

Procedure volumes, GLP-1 demand shifts, and hospital labor normalization are key drivers for providers and devices. Watch drug pricing policy and patent replacement pipelines for large incumbents.

The best opportunities usually come from segment selection, not broad sector timing. Quality compounders and speculative clinical-stage names coexist, so discipline on valuation matters.

Learn

Understanding the Healthcare Sector

What Is the Healthcare Sector?

Healthcare under GICS groups companies tied to medicine, patient care, diagnostics, life sciences, or health insurance — from large pharma and biotech to hospital systems, device makers, and health tech vendors.

Drug makers and insurers are valued on cash flow and pricing power. Biotech and devices are more about pipeline quality and product adoption. XLV gives a large-cap snapshot, but the full sector has a wider range of business models.

How to Invest in Healthcare Stocks

XLV offers broad exposure to established healthcare leaders. Stock selection is more useful for targeted pharma, managed care, device, or biotech exposure.

Key risks: regulation, reimbursement changes, patent cliffs, trial failures, and utilization shifts. In defensive phases, investors favor insurers and large-cap pharma. In risk-on phases, biotech pipelines and high-growth medtech get attention.

Use the screener to separate recurring cash flow businesses from binary-event stories. Margin stability, balance sheet strength, and valuation work best when compared within the right sub-group.

Explore Further

Related Themes & Screens in Healthcare

ThemeBiotech Healthcare

Frequently Asked Questions

Healthcare includes pharma, biotech, insurers, hospitals, device makers, diagnostics, and life sciences tools. The screener above shows the sector list with sortable data.

Explore More

Other Market Sectors

Dive into other sector analyses with performance tracking, valuation metrics, and industry breakdowns.

Technology Sector Stocks: Performance, Valuations & Industry Comps

XLK

Screen and research technology sector stocks with daily updated valuations, performance charts, and pre-filtered metrics for software, semiconductors, and hardware in 2026.

Financial Services Sector Stocks: Performance, Valuations & Industry Comps

XLF

Screen and research financial services sector stocks with daily updated valuations, yields, and pre-filtered metrics for banks, insurance, and payments in 2026.

Consumer Cyclical Sector Stocks: Performance, Valuations & Industry Comps

XLY

Screen and research consumer cyclical sector stocks with daily updated valuations, margins, and pre-filtered metrics for retail, autos, and restaurants in 2026.

Consumer Defensive Sector Stocks: Performance, Valuations & Industry Comps

XLP

Screen and research consumer defensive sector stocks with daily updated valuations, dividend yields, and metrics for food, household goods, and staples retail in 2026.

Energy Sector Stocks: Performance, Valuations & Industry Comps

XLE

Screen and research energy sector stocks with daily updated valuations, free cash flows, and metrics for oil, gas, refining, and service companies in 2026.

Basic Materials Sector Stocks: Performance, Valuations & Industry Comps

XLB

Screen and research basic materials sector stocks with daily updated valuations, commodity metrics, and pre-filtered metrics for chemicals, metals, and packaging in 2026.

View All Sectors

Ready to Build Your Healthcare Portfolio?

Use our powerful screener to filter Healthcare stocks by market cap, valuation, profitability, and dozens of other fundamental metrics.

Open Full ScreenerBrowse Stock Screens

100+ Metrics

Valuation, growth, profitability, technicals

Daily Updates

Prices, fundamentals, and estimates refreshed overnight

Save & Share

Bookmark custom screens and track over time

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
Performance Dashboard

How the Healthcare sector has traded against the market

Track the XLV sector ETF performance vs S&P 500. The basket shows equal-weight returns of top 50 stocks by market cap.

Sector ETF
XLV+17.2%
S&P 500 Index
SPY+9.7%
Equal-Weight Basket
Basket+22.3%
XLV Sector ETF (Solid Line)S&P 500 Index Benchmark (Dashed Line)Equal-Weight Sector Basket (Solid Line · Top 50 Stocks)

Top 1M Performers

Momentum Leaders

Gainers
IDXX$685.05

IDEXX Laboratories, Inc.

+24.1%
YTD +3%·$54.04B
EW$103.19

Edwards Lifesciences Corporation

+19.1%
YTD +22%·$59.42B
REGN$931.98

Regeneron Pharmaceuticals, Inc.

+18.1%
YTD +19%·$96.01B
GEHC$81.31

GE HealthCare Technologies Inc.

+17.4%
YTD -1%·$36.73B
SNY$46.60

Sanofi

+16.4%
YTD -4%·$111.91B

Bottom 1M Performers

Momentum Underperformers

Decliners
NTRA$275.91

Natera, Inc.

-27.4%
YTD +27%·$39.51B
UNH$345.98

UnitedHealth Group Incorporated

-18.8%
YTD -2%·$314.2B
VEEV$266.14

Veeva Systems Inc.

-17%
YTD +20%·$43.23B
CVS$82.13

CVS Health Corp.

-13.6%
YTD -0%·$104.79B
RVMD$162.29

Revolution Medicines, Inc.

-12.5%
YTD +102%·$34.5B

Market Comparison

Healthcare vs S&P 500 in one glance

Against the S&P 500, Healthcare currently trades at 32.9x trailing earnings versus 23.7x for the broad market. This premium is backed by stronger underlying fundamentals, with the sector delivering better margins or returns on equity than the broader index.

Valuation

Pricier

39% above S&P 500 trailing P/E

Sector vs Market

MetricHealthcareS&P 500Winner
Trailing P/E32.9x23.7xS&P 500 cheaper
Forward P/E22.2x20.9xS&P 500 cheaper
EV/EBITDA18.5x17.3xS&P 500 cheaper

Historical Context

1-year premiumAbove normal

78th percentile; range 25.5x to 35.0x

5-year premiumRich vs history

87th percentile; range 18.1x to 35.0x

Quality

Higher quality

Net margin 14.1% vs 27.0%; ROE 120.1% vs 55.8%

Sector vs Market

MetricHealthcareS&P 500Winner
Net Margin14.1%27.0%S&P 500 stronger
ROE120.1%55.8%Sector stronger

Absolute Health (TTM)

Revenue Growth7.9%
Gross Margin64.2%
FCF Margin16.9%

Income

Higher yield

Sector yield 1.41% vs 1.06%

Sector vs Market

MetricHealthcareS&P 500Winner
Dividend Yield1.4%1.1%Sector yields more
Industry Breakdown

Where the real weight sits inside Healthcare

These cards are built from the full sector universe, then ranked by market cap so you can see which pockets are leading, rich, resilient, or dangerously concentrated.

Industry Scoreboard

Fast scan of Healthcare industry setups

Use this table to spot heavyweights, cheap pockets, leaders, and genuinely beaten-down areas before opening the detailed cards below.

Big Pharma

14 stocks

45.4%

$4.3T

Leading

-1.5% median 3M

Fair

15.1x median Fwd P/E

High

23.3% median ROE

Weak

6.3% rev growth

Watchlist

Concentrated

Medical Devices

109 stocks

9.4%

$894.99B

Neutral

-24.6% median 3M

Fair

21.1x median Fwd P/E

Mixed

-11.3% median ROE

Strong

11.0% rev growth

Watchlist

Diversified

Health Insurers

10 stocks

7.2%

$681.66B

Leading

-6.4% median 3M

Cheap

13.5x median Fwd P/E

Mixed

12.0% median ROE

Weak

6.8% rev growth

Mixed

One-name heavy

Life Science Tools

33 stocks

6.8%

$640.85B

Leading

+7.6% median 3M

Premium

28.8x median Fwd P/E

Mixed

-8.4% median ROE

Weak

4.8% rev growth

Expensive Leader

Concentrated

Vaccines & Infectious Disease

36 stocks

3.5%

$333.68B

Lagging

-28.3% median 3M

Cheap

10.3x median Fwd P/E

Mixed

-29.7% median ROE

Strong

9.1% rev growth

Beaten Down

One-name heavy

Immunology Biotech

75 stocks

3.2%

$306.42B

Neutral

-35.0% median 3M

Cheap

21.7x median Fwd P/E

Mixed

-40.0% median ROE

Weak

-14.5% rev growth

Mixed

Concentrated

Drug Distributors & Pharmacies

15 stocks

3.0%

$284.7B

Leading

-5.0% median 3M

Fair

21.7x median Fwd P/E

Mixed

8.8% median ROE

Weak

4.9% rev growth

Mixed

One-name heavy

Specialty & Generic Drugs

58 stocks

2.9%

$278.05B

Leading

-11.1% median 3M

Cheap

9.5x median Fwd P/E

Mixed

5.5% median ROE

Strong

9.5% rev growth

Attractive

Diversified

Rare Disease Biotech

40 stocks

2.8%

$262.79B

Leading

-17.9% median 3M

Fair

25.5x median Fwd P/E

Mixed

-36.5% median ROE

Average

37.0% rev growth

Mixed

One-name heavy

Healthcare Providers

54 stocks

2.7%

$251.91B

Leading

-13.9% median 3M

Cheap

17.8x median Fwd P/E

Mixed

8.7% median ROE

Average

10.2% rev growth

Mixed

Concentrated

Oncology Biotech

144 stocks

2.4%

$228.25B

Lagging

-36.8% median 3M

Fair

36.1x median Fwd P/E

Mixed

-50.5% median ROE

Average

9.2% rev growth

Mixed

Diversified

Diagnostics & Lab Testing

50 stocks

2.4%

$226.48B

Neutral

-20.2% median 3M

Fair

36.8x median Fwd P/E

Mixed

-14.1% median ROE

Strong

11.5% rev growth

Watchlist

Diversified

Medical Supplies & Consumables

21 stocks

1.7%

$165.57B

Leading

-2.3% median 3M

Fair

20.5x median Fwd P/E

Mixed

6.0% median ROE

Weak

5.3% rev growth

Mixed

Concentrated

Neuroscience Biotech

72 stocks

1.0%

$96.18B

Lagging

-35.6% median 3M

Fair

21.4x median Fwd P/E

Mixed

-53.8% median ROE

Average

16.2% rev growth

Mixed

Concentrated

Contract Research & Manufacturing

12 stocks

1.0%

$95.27B

Leading

+3.0% median 3M

Premium

21.5x median Fwd P/E

Mixed

-5.8% median ROE

Weak

1.6% rev growth

Expensive Leader

Concentrated

Healthcare Software & Telehealth

39 stocks

1.0%

$92.51B

Neutral

-13.8% median 3M

Fair

21.1x median Fwd P/E

High

2.3% median ROE

Average

6.5% rev growth

Watchlist

One-name heavy

Cell & Gene Therapy

103 stocks

0.9%

$89.61B

Lagging

-41.2% median 3M

Premium

24.5x median Fwd P/E

Mixed

-57.4% median ROE

Weak

-9.2% rev growth

Broken

Diversified

Eye & Dental Care

14 stocks

0.9%

$87.81B

Leading

-12.5% median 3M

Fair

18.2x median Fwd P/E

High

-1.7% median ROE

Strong

6.0% rev growth

Watchlist

Concentrated

Medical Imaging & Radiation

19 stocks

0.8%

$75.79B

Neutral

-35.3% median 3M

Fair

19.6x median Fwd P/E

Weak

-37.6% median ROE

Average

14.2% rev growth

Mixed

One-name heavy

Metabolic & Cardiovascular Biotech

44 stocks

0.4%

$41.35B

Lagging

-35.3% median 3M

Cheap

128.7x median Fwd P/E

Mixed

-46.8% median ROE

Average

30.0% rev growth

Beaten Down

Diversified

Drug Discovery Platforms

27 stocks

0.3%

$23.92B

Neutral

-18.8% median 3M

Fair

52.7x median Fwd P/E

Mixed

-47.2% median ROE

Strong

33.3% rev growth

Watchlist

One-name heavy

Ophthalmology Biotech

15 stocks

0.2%

$17.91B

Neutral

-41.9% median 3M

Premium

- median Fwd P/E

Mixed

-59.6% median ROE

Weak

-9.7% rev growth

Mixed

One-name heavy

Cannabis

14 stocks

0.0%

$2.78B

Lagging

-38.6% median 3M

Cheap

13.0x median Fwd P/E

Mixed

-8.6% median ROE

Strong

13.1% rev growth

Beaten Down

Concentrated

Other

6 stocks

0.0%

$3M

Neutral

-6.1% median 3M

Cheap

0.0x median Fwd P/E

Weak

-143.9% median ROE

Strong

139.1% rev growth

Attractive

One-name heavy

Showing 24 of 24 industries in Healthcare.

Setup is a quick read of value, quality, growth, momentum, and concentration together.

Big Pharma

Fairly pricedHigh qualityLeadingWeak growthConcentrated

Big Pharma is a core pocket of healthcare, still leading on price action; growth is softer than the sector average, business quality is stronger than the sector median, and valuation is close to sector norms. Leadership is concentrated in a few names.

Median 3M return

-1.5%

Forward P/E

15.1x

Top 3 weight

56.7%

Market cap

$4.3T

Coverage

14 stocks

Breadth

43% pos. in 3M

Explore entire industry
→

Earnings Calendar

Upcoming Earnings in Healthcare

Earnings reports are the biggest near-term catalysts for sector moves. Track which names report in the next 60 days and size your positions accordingly.

A

$49.52B

Agilent Technologies, Inc.

Mon, Nov 23

3d

MDT

$129.17B

Medtronic plc

Tue, Nov 24

4d

VEEV

$42.71B

Veeva Systems Inc.

Thu, Dec 3